EDGAR Filing Documents for 0001628280-22-018378

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001628280-22-018378

Filing Date

2022-07-01

Accepted

2022-07-01 16:13:34

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	pointbiopharma-sx3.htm	S-3	480101
2	EX-FILING FEES	exhibit107-sx3.htm	EX-FILING FEES	28958
3	EX-1.2	exhibit12-equitydistributi.htm	EX-1.2	277895
4	EX-4.6	exhibit46-formofseniorinde.htm	EX-4.6	386713
5	EX-4.7	exhibit47-formofsubordinat.htm	EX-4.7	357479
6	EX-5.1	exhibit51-opinionofbassber.htm	EX-5.1	40583
7	EX-5.2	exhibit52-sx3.htm	EX-5.2	16441
8	EX-23.1	exhibit231-consentofarmani.htm	EX-23.1	3779
9		bassberrysims.jpg	GRAPHIC	8179
10		bassberrysims1a.jpg	GRAPHIC	8179
11		image_0a.jpg	GRAPHIC	26798
12		image_1a.jpg	GRAPHIC	28716
13		point-logoxcoloura.jpg	GRAPHIC	17537
	Complete submission text file	0001628280-22-018378.txt		1716214

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268

Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957

POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-265981 | Film No.: 221061531
SIC: 2834 Pharmaceutical Preparations